« Back to Record
Citation APA

Noel, C., Abramowicz, D., Durand, D., Mourad, G., Lang, P., Kessler, M., Charpentier, B., Touchard, G., Berthoux, F., Merville, P., Ouali, N., Squifflet, J.-P., Bayle, F., Wissing, K. M., & Hazzan, M. (2009). Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. Journal of the American Society of Nephrology, 20(6), 1385-1392. doi:10.1681/ASN.2008101037


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/86433

Noel, C., Abramowicz, D., Durand, D., Mourad, G., Lang, P., Kessler, M., Charpentier, B., Touchard, G., Berthoux, F., Merville, P., Ouali, N., Squifflet, J.-P., Bayle, F., Wissing, K. M., & Hazzan, M. (2009). Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. Journal of the American Society of Nephrology, 20(6), 1385-1392. doi:10.1681/ASN.2008101037